Merck requests US emergency approval for COVID-19 tablet

Published October 11, 2021 1:20pm ET



Merck, one of America’s largest pharmaceutical companies, put in an emergency use authorization request for a pill that may be the first to treat COVID-19.

On Friday, the pharmaceutical company released a statement declaring that it was preparing to apply for emergency use of its molnupiravir tablet with the Food and Drug Administration. If approved by the FDA, the tablet would be the first oral antiviral medicine to be used to treat the coronavirus, Reuters reported.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.